Meningitis B vaccine (2026)
Estimated value
—
Awarded value
—
Suppliers
1
Lots
1
1 awarded
Published
09 Sept 2025
Description
The provision of a vaccine to protect against meningococcal B (MenB) disease, to be used in the national childhood immunisation programme, as well as a targeted programme to protect at risk adults against Gonorrhoea. This notice provides an indication to the market of UKHSA's intention to enter into negotiations with GlaxoSmithKline (UK) Limited, with the objective of awarding a contract for the supply of the meningococcal group B vaccine, in accordance with JCVI advice.
Scope
- Reference
- C352798
- Commercial tool
- Standalone contract
Submission & procedure
- Procedure
- Direct award
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
30 Sept 2026
Contract end
30 Sept 2028
Awarded to